VICTORIA ODOH: Open Payments
NPI 1265048300 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| ABBVIE INC. | 2 | $54 |
| QOL Medical, LLC | 1 | $40 |
| Novo Nordisk Inc | 1 | $30 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| PFIZER INC. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, Sucraid, Wegovy, RINVOQ, ZENPEP, VOQUEZNA.
Industry payments across WA — which companies pay providers there.
